Worldwide Shipping Apc/fire™ 750 Anti-human Cd90 (thy1) For Home [iTkYy6HK]
APC/Fire™ 750 Anti-Human CD90 (Thy1) The APC/Fire™ 750 Anti-Human CD90 (Thy1) is a powerful tool for researchers studying hematopoietic stem cells and various cell types. This monoclonal antibody, clone 5E10, is designed to target human CD90, also kn
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Worldwide Shipping Apc/fire™ 750 Anti-human Cd90 (thy1) For Home [iTkYy6HK]
APC/Fire™ 750 Anti-Human CD90 (Thy1)
The APC/Fire™ 750 Anti-Human CD90 (Thy1) is a powerful tool for researchers studying hematopoietic stem cells and various cell types. This monoclonal antibody, clone 5E10, is designed to target human CD90, also known as Thy-1, a crucial protein expressed on a wide range of cells. With its high specificity and affinity, this antibody is ideal for flow cytometry and other immunological applications.Product Features and Specifications
The APC/Fire™ 750 conjugation provides exceptional brightness and long-wavelength emission, making it perfect for high-throughput analysis. This antibody is derived from mouse IgG1, κ, and is optimized for use in human samples. Its reactivity with human cells ensures reliable results in various research settings. Key features include:- Bright APC/Fire™ 750 Conjugation: Offers superior brightness for enhanced detection sensitivity.
- Monoclonal Antibody: Ensures consistent and reproducible results across experiments.
Practical Applications
The APC/Fire™ 750 Anti-Human CD90 (Thy1) is a versatile reagent that can be used in a variety of research applications, including:- Flow Cytometry: Identify and analyze CD90+ cells in complex samples.
- Immunohistochemistry: Visualize CD90 expression in tissue sections.
What Our Customers Say
Absolutely no complaints!
This is a very well-built, very great tool.
- Malaysia P..
Absolutely no complaints!
This is a really great and useful item.
- Bernice C..
Absolutely no complaints!
It’s a very clever, extremely well-made tool.
- Nicolas D..